Alexander Pickett

Managing Director at Juvenesence

Alexander Pickett is Managing Director at Juvenescence, where he oversees new opportunity onboarding. He has worked with Juvenescence’s founding partners at Mediqventures, Ltd., a multi-family investment partnership and merchant bank, where he supported existing investments at Portage Biotech Inc., including Portage Pharma Ltd. and Biohaven (NYSE:BHVN). Alexander was on the founding team of SalvaRx Limited, a cancer immunotherapy-focused investment company that was later merged into Portage Biotech.

Prior to joining Mediqventures, Alexander was an associate at Flatley Venture Capital, a cystic fibrosis-focused investment arm of the John J. Flatley Company, where he was responsible for investment analysis and scientific due diligence. Alexander co-founded Real Life Sciences, a start-up focused on software-based patient-engagement solutions to improve patient recruitment to clinical trials. Alexander has a BA in Molecular and Cellular Biology from Harvard College, where he was a Microbial Studies Initiative Undergraduate Fellow and a team member in the International Genetically Engineered Machines Competition.